Autotaxin emerges as a therapeutic target for idiopathic pulmonary fibrosis: limiting fibrosis by limiting lysophosphatidic acid synthesis.

ABSTRACT:

SUBMITTER: Tager AM 

PROVIDER: S-EPMC3547105 | biostudies-literature | 2012 Nov

REPOSITORIES: biostudies-literature